お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
966744

急性非代償性心不全 (ADHF):市場分析、疫学、市場予測 (2030年)

Acute Decompensated Heart Failure (ADHF) - Epidemiology Insight - 2030

出版日: 受注生産 | 発行: DelveInsight Business Research LLP | ページ情報: 英文 100 Pages | 納期: 約10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
急性非代償性心不全 (ADHF):市場分析、疫学、市場予測 (2030年)
出版日: 受注生産
発行: DelveInsight Business Research LLP
ページ情報: 英文 100 Pages
納期: 約10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の主要7カ国 - 米国、欧州主要5ヶ国 (EU5:フランス・ドイツ・イタリア・スペイン・英国)、日本 - における急性非代償性心不全 (ADHF) の疫学的動向と今後の市場見通しについて分析し、疾患の概要や市場の基本構造、現在の治療法とアンメットニーズ、世界全体/各国の市場規模 (過去3年間・今後11年間分)、といった情報を取りまとめてお届けいたします。

目次

第1章 主な考察

第2章 急性非代償性心不全 (ADHF):エグゼクティブサマリー

第3章 急性非代償性心不全 (ADHF):疾患概要

  • イントロダクション
  • 兆候と症状
  • 病態生理
  • 危険因子
  • 診断基準

第4章 ペイシェント・ジャーニー

第5章 急性非代償性心不全 (ADHF) の疫学と患者人口

  • 疫学分析のポイント
  • 仮定と理論的根拠:主要7ヶ国
  • 疫学シナリオ:主要7ヶ国
    • 急性非代償性心不全 (ADHF):主要7ヶ国における疫学シナリオ (2017年~2030年)
  • 米国の疫学的動向
    • 米国国内の急性非代償性心不全 (ADHF) の疫学シナリオ (2017年~2030年)
  • 欧州5ヶ国:国別の疫学的動向
    • ドイツの疫学的動向
    • フランスの疫学的動向
    • イタリアの疫学的動向
    • スペインの疫学的動向
    • 英国の疫学的動向
  • 日本の疫学的動向
    • 日本国内の急性非代償性心不全 (ADHF) の疫学シナリオ (2017年~2030年)

第6章 治療アルゴリズム、現在の治療・診療方法

  • 急性非代償性心不全 (ADHF) の治療・管理方法
  • 急性非代償性心不全 (ADHF) の治療アルゴリズム

第7章 業界の有識者 (KOL) の見解

第8章 アンメットニーズ

第9章 付録

第10章:DelveInsightのサービス内容

第11章 免責事項

第12章:DelveInsightについて

図表

List of Tables

  • Table 1: Acute Decompensated Heart Failure (ADHF) Epidemiology in 7MM (2017-2030)
  • Table 2: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Table 3: Acute Decompensated Heart Failure (ADHF) Epidemiology in the United States (2017-2030)
  • Table 4: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in the United States (2017-2030)
  • Table 5: Acute Decompensated Heart Failure (ADHF) Epidemiology in Germany (2017-2030)
  • Table 6: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Germany (2017-2030)
  • Table 7: Acute Decompensated Heart Failure (ADHF) Epidemiology in France (2017-2030)
  • Table 8: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in France (2017-2030)
  • Table 9: Acute Decompensated Heart Failure (ADHF) Epidemiology in Italy (2017-2030)
  • Table 10: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Italy (2017-2030)
  • Table 11: Acute Decompensated Heart Failure (ADHF) Epidemiology in Spain (2017-2030)
  • Table 12: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Spain (2017-2030)
  • Table 13: Acute Decompensated Heart Failure (ADHF) Epidemiology in the United Kingdom (2017-2030)
  • Table 14: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Table 15: Acute Decompensated Heart Failure (ADHF) Epidemiology in Japan (2017-2030)
  • Table 16: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Japan (2017-2030)

List of Figures

  • Figure 1: Acute Decompensated Heart Failure (ADHF) Epidemiology in 7MM (2017-2030)
  • Figure 2: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Figure 3: Acute Decompensated Heart Failure (ADHF) Epidemiology in the United States (2017-2030)
  • Figure 4: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in the United States (2017-2030)
  • Figure 5: Acute Decompensated Heart Failure (ADHF) Epidemiology in Germany (2017-2030)
  • Figure 6: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Germany (2017-2030)
  • Figure 7: Acute Decompensated Heart Failure (ADHF) Epidemiology in France (2017-2030)
  • Figure 8: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in France (2017-2030)
  • Figure 9: Acute Decompensated Heart Failure (ADHF) Epidemiology in Italy (2017-2030)
  • Figure 10: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Italy (2017-2030)
  • Figure 11: Acute Decompensated Heart Failure (ADHF) Epidemiology in Spain (2017-2030)
  • Figure 12: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Spain (2017-2030)
  • Figure 13: Acute Decompensated Heart Failure (ADHF) Epidemiology in the United Kingdom (2017-2030)
  • Figure 14: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Figure 15: Acute Decompensated Heart Failure (ADHF) Epidemiology in Japan (2017-2030)
  • Figure 16: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Japan (2017-2030)

The table of contents is not exhaustive; will be provided in the final report

目次
Product Code: DIEI1019

DelveInsight's 'Acute Decompensated Heart Failure (ADHF) - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Acute Decompensated Heart Failure (ADHF) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Acute Decompensated Heart Failure (ADHF) Understanding

The DelveInsight Acute Decompensated Heart Failure (ADHF) epidemiology report gives a thorough understanding of the Acute Decompensated Heart Failure (ADHF) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Acute Decompensated Heart Failure (ADHF) in the US, Europe, and Japan. The report covers the detailed information of the Acute Decompensated Heart Failure (ADHF) epidemiology scenario in seven major countries (US, EU5, and Japan).

Acute Decompensated Heart Failure (ADHF) Epidemiology Perspective by DelveInsight

The Acute Decompensated Heart Failure (ADHF) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Acute Decompensated Heart Failure (ADHF) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Acute Decompensated Heart Failure (ADHF) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Acute Decompensated Heart Failure (ADHF) Detailed Epidemiology Segmentation

The Acute Decompensated Heart Failure (ADHF) epidemiology covered in the report provides historical as well as forecasted Acute Decompensated Heart Failure (ADHF) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Acute Decompensated Heart Failure (ADHF) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report:

  • The Acute Decompensated Heart Failure (ADHF) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Acute Decompensated Heart Failure (ADHF) Epidemiology Report and Model provide an overview of the risk factors and global trends of Acute Decompensated Heart Failure (ADHF) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Acute Decompensated Heart Failure (ADHF) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Acute Decompensated Heart Failure (ADHF)
  • The report provides the segmentation of the Acute Decompensated Heart Failure (ADHF) epidemiology

Report Highlights:

  • 11-Year Forecast of Acute Decompensated Heart Failure (ADHF) epidemiology
  • 7MM Coverage
  • Total Cases of Acute Decompensated Heart Failure (ADHF)
  • Total Cases of Acute Decompensated Heart Failure (ADHF) according to segmentation
  • Diagnosed cases of Acute Decompensated Heart Failure (ADHF)

KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Acute Decompensated Heart Failure (ADHF) ?
  • What are the key findings pertaining to the Acute Decompensated Heart Failure (ADHF) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Acute Decompensated Heart Failure (ADHF) across the 7MM during the forecast period (2017-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Acute Decompensated Heart Failure (ADHF) ?
  • What are the currently available treatments of Acute Decompensated Heart Failure (ADHF) ?

Reasons to buy:

  • The Acute Decompensated Heart Failure (ADHF) Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Acute Decompensated Heart Failure (ADHF) market
  • Quantify patient populations in the global Acute Decompensated Heart Failure (ADHF) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Acute Decompensated Heart Failure (ADHF) therapeutics in each of the markets covered
  • Understand the magnitude of Acute Decompensated Heart Failure (ADHF) population by its epidemiology
  • The Acute Decompensated Heart Failure (ADHF) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Executive Summary of Acute Decompensated Heart Failure (ADHF)

3. Acute Decompensated Heart Failure (ADHF) : Disease Background and Overview

  • 3.1. Introduction
  • 3.2. Sign and Symptoms
  • 3.3. Pathophysiology
  • 3.4. Risk Factors
  • 3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

  • 5.1. Epidemiology Key Findings
  • 5.2. Assumptions and Rationale: 7MM
  • 5.3. Epidemiology Scenario: 7MM
    • 5.3.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in the 7MM (2017- 2030)
  • 5.4. United States Epidemiology
    • 5.4.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in the United States (2017- 2030)
  • 5.5. EU-5 Country-wise Epidemiology
    • 5.5.1. Germany Epidemiology
      • 5.5.1.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in Germany (2017- 2030)
    • 5.5.2. France Epidemiology
      • 5.5.2.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in France (2017- 2030)
    • 5.5.3. Italy Epidemiology
      • 5.5.3.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in Italy (2017- 2030)
    • 5.5.4. Spain Epidemiology
      • 5.5.4.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in Spain (2017- 2030)
    • 5.5.5. United Kingdom Epidemiology
      • 5.5.5.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in the United Kingdom (2017-2030)
  • 5.6. Japan Epidemiology
    • 5.6.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

  • 6.1. Acute Decompensated Heart Failure (ADHF) Treatment and Management
  • 6.2. Acute Decompensated Heart Failure (ADHF) Treatment Algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

  • 9.1. Bibliography
  • 9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

The table of contents is not exhaustive; will be provided in the final report

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.